GSE135350 dexamethasone 2 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE135350_dexamethasone_2_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE135350_dexamethasone_2_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE135350_dexamethasone_2_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE135350_dexamethasone_2_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

ribosomal protein SA 2

Gene

high mobility group box 1 pseudogene 5

Gene

brain cytoplasmic RNA 1

Gene

long intergenic non-protein coding RNA 632

Gene

cholesterol induced regulator of metabolism RNA

Gene

TRG antisense RNA 1

Gene

CCDC26 long non-coding RNA

Gene

TSIX transcript, XIST antisense RNA

Gene

long intergenic non-protein coding RNA 2987

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    ribosomal protein SA 2


  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    brain cytoplasmic RNA 1


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    cholesterol induced regulator of metabolism RNA


  • Gene

    TRG antisense RNA 1


  • Gene

    CCDC26 long non-coding RNA


  • Gene

    TSIX transcript, XIST antisense RNA


  • Gene

    long intergenic non-protein coding RNA 2987

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.